Events

• 29 April 2026

  Seminar

  Fleming's External Seminar on Wednesday 29/4/26 at 13:00 - Lecture theatre, "T cells in cardiovascular disease and cardiotoxicity: Drivers of disease, opportunities for therapy", by Marinos Kallikourdis, Associate Professor of Immunology and General Pathology, Department of Biomedical Sciences, Humanitas University and Group Leader, Adaptive Immunity Laboratory, IRCCS Humanitas Research Hospital.

• 24 April 2026

  ERA Chair Sessions

  Fleming's External Seminar on Friday 24/4/26 at 13:00 - Lecture theatre, "The Edinburgh Genome Foundry - Robotic Precision & Academic Expertise", by Dr. Rennos Fragkoudis, Head of Edinburgh Genome Foundry, The University of Edinburgh, United Kingdom.

• 2 April 2026

  Seminar

  Fleming's External Seminar on Thursday 2/4/26 at 13:00 - Lecture theatre, "Combining native MS with synthetic biology to target intricate membrane proteins", by Idlir Liko, PhD, Ellison Institute of Technology, Oxford - UK.

• 27 March 2026

  Seminar

  Fleming's External Seminar on Friday 27/3/26 at 13:00 - Lecture theatre, "Revisiting Complement pathobiology: Emerging paradigms and clinical applications", by Dimitris Mastellos, PhD, Director of Research, Immunochemistry Group, Division of Biodiagnostic Sciences and Technologies, INRASTES, NCSR Demokritos.

• 20 February 2026

  Seminar

  Fleming's External Seminar on Friday 20/2/26 at 13:00 - Lecture theatre, "Transcriptional Control of Midbrain Identity to Genome-Wide Functional Screens in Neurodegeneration", by Emmanouil (Manos) Metzakopian, Chief Executive Officer & Co-Founder, CellCodex Technology Ltd (Cambridge, UK),Visiting Researcher Cambridge University and Babraham Research Institute.

• 6 February 2026

  ERA Chair Sessions

  Fleming's External Seminar on Friday 6/2/26 at 13:00 - Lecture theatre, "One plus one equals zero - Rethinking the genetic architecture of human disorders", by Dr Nicholas Katsanis, Co-Founder, EVP and CSO, Galatea Bio, Co-Founder, Antithesis Therapeutics, USA.